SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.17 Cr | ₹3.46 Cr | ₹5.62 Cr | ₹5.62 Cr | ₹1.57 Cr |
What is the latest Contingent Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.17 Cr |
| Mar2024 | ₹3.46 Cr |
| Mar2023 | ₹5.62 Cr |
| Mar2022 | ₹5.62 Cr |
| Mar2021 | ₹1.57 Cr |
How is Contingent Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.17 Cr | 20.41 | |
| Mar2024 | ₹3.46 Cr | -38.45 | |
| Mar2023 | ₹5.62 Cr | 0.00 | |
| Mar2022 | ₹5.62 Cr | 257.96 | |
| Mar2021 | ₹1.57 Cr | - | |
Compare Contingent Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,259.5 Cr | -2.4% | -3.4% | 3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -2.4% |
-3.4% |
3% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses